Ashland Stock Price, News & Analysis

Ashland (NYSE: ASH) will release fourth-quarter fiscal 2025 earnings at approximately 5:00 p.m. ET on Tuesday, November 4, 2025, and will host a live webcast with securities analysts at 9:00 a.m. ET on Wednesday, November 5, 2025.

The webcast will include an executive summary, detailed remarks, and a slide presentation posted simultaneously in the Investor Relations section at http://investor.ashland.com. Participants may join by phone via the provided registration link; callers are encouraged to dial in 15 minutes early. The live event and supporting materials will be archived on Ashland's website for 12 months.

Presenters include Guillermo Novo (chair and CEO), William Whitaker (SVP and CFO), Dago Caceres (SVP, GM, specialty additives), Alessandra Faccin (SVP, GM, life sciences and intermediates), Jim Minicucci (SVP, GM, personal care), and Sandy Klugman (director, investor relations).

Ashland (NYSE: ASH) announced that Sandy Klugman joined as director, Investor Relations, effective October 13, 2025. He reports to William Whitaker, senior vice president and chief financial officer.

Klugman brings over two decades of investor relations, equity research, and investment analysis experience, is a CFA charterholder, and previously served as senior vice president, Investor Relations at ICR. His background includes sell-side analyst roles at Susquehanna, Vertical Research Partners, Credit Suisse, and UBS, and buy-side roles at Charter Oak Partners and Millgate Capital. He holds an MBA from Chicago Booth and a BS in Communication from Cornell.

He will serve as the primary liaison to the investment community, focusing on disclosure of financial performance, strategy, and long-term value proposition.

Ashland (NYSE: ASH) announced that a production unit at its Calvert City, Kentucky facility is temporarily offline due to an equipment-related incident. The company expects repairs, including fabrication and installation of new equipment, to be completed during fiscal Q1 2026.

While the site remains partially operational, Ashland does not anticipate any impact on customer deliveries or sales commitments, supported by finished goods inventory and production from unaffected units. The company estimates an Adjusted EBITDA impact of approximately $10 million in fiscal 2026, with minimal impact in fiscal 2025. The next update will be provided during Q4 earnings release.

Ashland (NYSE: ASH) has announced its board of directors has declared a quarterly cash dividend of $0.415 per share on the company's common stock. The dividend will be paid on September 15, 2025, to stockholders of record as of September 1, 2025. The company reported 45,709,431 outstanding shares of common stock as of July 31, 2025.

Ashland (NYSE: ASH) reported Q3 fiscal 2025 results with sales of $463 million, down 15% year-over-year. The company recorded a significant net loss of $742 million, primarily due to a $706 million non-cash goodwill impairment charge.

Key financial metrics include Adjusted EBITDA of $113 million (down 19%) and Adjusted Income from Continuing Operations of $48 million ($1.04 per diluted share). Portfolio Optimization initiatives reduced sales by approximately $53 million or 10%. The company generated $114 million in operating cash flow and $108 million in Ongoing Free Cash Flow.

Ashland narrowed its FY2025 outlook, projecting sales of $1.825-1.850 billion and Adjusted EBITDA of $400-410 million, with expectations weighted toward the lower end of the range due to ongoing market uncertainty.

Ashland (NYSE: ASH) has appointed William C. Whitaker as senior vice president and chief financial officer, effective July 18, 2025. Whitaker, who was serving as interim CFO, has been with Ashland since 2015, holding various leadership positions in corporate development, treasury, financial planning and analysis, and investor relations.

Whitaker brings valuable experience from his previous roles in private equity and transaction advisory services. He holds a Bachelor's degree in Finance from Ohio State University and is a Chartered Financial Analyst (CFA). The appointment was announced by Guillermo Novo, Ashland's chair and CEO, who expressed confidence in Whitaker's leadership abilities.

Ashland (NYSE: ASH) has scheduled its third-quarter fiscal 2025 earnings release for July 29, 2025, at 5 p.m. ET, followed by a live webcast with analysts on July 30, 2025, at 10 a.m. ET.

Key executives participating in the presentation include Guillermo Novo (Chair and CEO), William Whitaker (Interim CFO), Dago Caceres (SVP, Specialty Additives), Alessandra Faccin (SVP, Life Sciences), and Jim Minicucci (SVP, Personal Care). The presentation materials will be available on Ashland's investor relations website, with an archived version accessible for 12 months post-event.

Ashland (NYSE: ASH) announced significant leadership changes in its operations team. Karl Bostaph, senior vice president of operations, will retire on October 1, 2025, after serving since joining Hercules in 1990, which Ashland acquired in 2008.

Wayne Muil, previously global director of operations for specialty additives, has been promoted to senior vice president of operations, effective immediately. Muil, who joined Ashland in 2024, brings over 25 years of experience in manufacturing and supply chain operations, including his role as vice president of manufacturing and engineering at Sadara Chemical Company.

To ensure continuity, Bostaph will serve as a special advisor for operations, working alongside Muil until his retirement to facilitate a seamless transition for customers and internal teams.

Ashland (NYSE: ASH) has provided an update on its $60 million manufacturing network optimization plan, announcing significant facility changes and strategic consolidations. The company will close its Parlin, New Jersey facility and transfer hydroxyethyl cellulose (HEC) production to Hopewell, Virginia. Additionally, Ashland will close its Chatham, New Jersey plant and move microbial protection production to Freetown, Massachusetts.

The optimization plan follows the completion of a $30 million restructuring initiative and includes major investments in facilities across the United States, Europe, China, Brazil, and India. The company is strengthening its core technologies, including vinyl pyrrolidone and derivatives (VP&D) and HEC, while expanding its global manufacturing footprint for injectables, tablet coatings, and biofunctionals businesses.